RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Delayed Hypersensitivity
Accession: DOID:9002605
browse the term
Definition: An increased reactivity to specific antigens mediated not by antibodies but by cells.
Synonyms: exact_synonym: Delayed Hypersensitivities; Tuberculin Type Hypersensitivity; Tuberculin-Type Hypersensitivities; Type IV Hypersensitivities; Type IV Hypersensitivity
narrow_synonym: REDUCED DELAYED HYPERSENSITIVITY
primary_id: MESH:D006968
alt_id: RDO:0002568
G
ABCA1
ATP binding cassette subfamily A member 1
ISO
ClinVar Annotator: match by term: Reduced delayed hypersensitivity
ClinVar
PMID:28492532
NCBI chr 9:75,948,831...76,096,136
Ensembl chr 9:104,076,516...104,224,188
G
ALB
albumin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19376187
NCBI chr 4:50,773,244...50,790,474
Ensembl chr 4:56,605,322...56,622,418
G
ANXA1
annexin A1
ISO
RGD
PMID:23267026
RGD:7421573
NCBI chr 9:51,647,404...51,665,990
Ensembl chr 9:71,929,728...71,948,779
G
BSCL2
BSCL2 lipid droplet biogenesis associated, seipin
ISO
ClinVar Annotator: match by term: Reduced delayed hypersensitivity
ClinVar
NCBI chr11:58,046,842...58,064,219
Ensembl chr11:61,399,314...61,416,494
G
CCL2
C-C motif chemokine ligand 2
ISO
protein:increased expression:dermis, neutrophil (rat)
RGD
PMID:8774140
RGD:8549532
NCBI chr17:22,528,154...22,530,091
Ensembl chr17:22,820,890...22,823,384
G
CCR1
C-C motif chemokine receptor 1
ISO
RGD
PMID:16493073
RGD:5688154
NCBI chr 3:46,107,526...46,114,229
Ensembl chr 3:47,214,688...47,215,755
G
CD40
CD40 molecule
ISO
RGD
PMID:15210767
RGD:7248442
NCBI chr20:42,455,711...42,467,139
Ensembl chr20:43,541,619...43,552,994
G
CTSS
cathepsin S
ISO
RGD
PMID:16631730
RGD:5687149
NCBI chr 1:126,084,249...126,118,221
Ensembl chr 1:129,733,996...129,768,318
G
CXCR3
C-X-C motif chemokine receptor 3
ISO
RGD
PMID:15884054
RGD:5143937
NCBI chr X:60,880,759...60,883,355
Ensembl chr X:70,933,160...70,935,756
G
FGF2
fibroblast growth factor 2
ISO
RGD
PMID:16507899
RGD:8554852
NCBI chr 4:115,005,136...115,076,369
Ensembl chr 4:126,149,813...126,214,942
G
GATA3
GATA binding protein 3
ISO
mRNA, protein:increased expression:spleen
RGD
PMID:16336837
RGD:2314191
NCBI chr10:8,075,951...8,105,573
Ensembl chr10:8,064,207...8,086,272
G
GNG3
G protein subunit gamma 3
ISO
ClinVar Annotator: match by term: Reduced delayed hypersensitivity
ClinVar
NCBI chr11:58,064,173...58,065,727
Ensembl chr11:61,416,381...61,418,002
G
HNF1A
HNF1 homeobox A
ISO
ClinVar Annotator: match by term: Reduced delayed hypersensitivity
ClinVar
PMID:11938027 PMID:24033266 PMID:24728327 PMID:25741868 PMID:25887915 PMID:28492532 PMID:29334895 More...
NCBI chr12:118,562,308...118,584,596
Ensembl chr12:121,932,671...121,955,911
G
ICAM1
intercellular adhesion molecule 1
ISO
RGD
PMID:8093459
RGD:8547692
NCBI chr19:9,821,402...9,837,021
Ensembl chr19:10,484,414...10,500,605
G
IFNG
interferon gamma
ISO
RGD
PMID:3139020
RGD:8157617
NCBI chr12:65,663,764...65,668,732
Ensembl chr12:68,448,861...68,453,829
G
IL13
interleukin 13
treatment
ISO
RGD
PMID:19951958
RGD:8549563
NCBI chr 5:128,073,863...128,078,453
Ensembl chr 5:134,235,788...134,240,548
G
IL17A
interleukin 17A
ISO
RGD
PMID:19373578
RGD:4888523
NCBI chr 6:51,736,269...51,740,538
Ensembl chr 6:53,004,820...53,009,074
G
LOC100972994
HLA class II histocompatibility antigen, DQ beta 1 chain
ISO
RGD
PMID:9834080
RGD:5147666
NCBI chr 6:32,237,395...32,244,201
Ensembl chr 6:33,353,599...33,360,272
G
ABCA6
ATP binding cassette subfamily A member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr17:63,006,916...63,069,941
Ensembl chr17:68,396,083...68,458,795
G
ASRGL1
asparaginase and isoaspartyl peptidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr11:57,700,104...57,750,371
Ensembl chr11:61,056,817...61,107,485
G
BCL2
BCL2 apoptosis regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr18:56,481,212...56,679,012
Ensembl chr18:59,802,443...59,992,100
G
BMP6
bone morphogenetic protein 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr 6:7,564,164...7,720,341
Ensembl chr 6:7,848,249...8,000,649
G
CALCRL
calcitonin receptor like receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr2B:74,622,892...74,728,067
Ensembl chr2B:192,422,283...192,463,064
G
CASP8
caspase 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr2B:88,490,611...88,542,132
Ensembl chr2B:206,669,544...206,696,468
G
CCL17
C-C motif chemokine ligand 17
ISO
RGD
PMID:15491423
RGD:1626251
NCBI chr16:37,678,518...37,689,350
Ensembl chr16:56,819,949...56,822,131
G
CCL19
C-C motif chemokine ligand 19
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17597826
NCBI chr 9:34,525,820...34,527,628
Ensembl chr 9:35,334,353...35,336,108
G
CCL5
C-C motif chemokine ligand 5
ISO
protein:increased expression:ear (mouse)
RGD
PMID:15491423
RGD:1626251
NCBI chr17:20,915,198...20,923,530
Ensembl chr17:21,210,798...21,219,172
G
CCR1
C-C motif chemokine receptor 1
ISO
RGD
PMID:18844696
RGD:5688176
NCBI chr 3:46,107,526...46,114,229
Ensembl chr 3:47,214,688...47,215,755
G
CCR2
C-C motif chemokine receptor 2
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:10899907 PMID:17374397
RGD:8661227
NCBI chr 3:46,255,725...46,263,285
Ensembl chr 3:47,361,124...47,368,312
G
CCR3
C-C motif chemokine receptor 3
ISO
RGD
PMID:22075493
RGD:6892916
NCBI chr 3:46,147,928...46,172,947
Ensembl chr 3:47,253,878...47,278,630
G
CCR5
C-C motif chemokine receptor 5
ISO
mRNA:increased expression:skin, lymph node (rat)
RGD
PMID:16977379
RGD:2325935
NCBI chr 3:46,273,096...46,278,471
Ensembl chr 3:47,380,321...47,381,379
G
CD36
CD36 molecule (CD36 blood group)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr 7:72,566,478...72,643,517
Ensembl chr 7:86,265,114...86,305,865
G
CIDEC
cell death inducing DFFA like effector c
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr 3:9,811,995...9,836,069
Ensembl chr 3:10,048,554...10,173,107
G
CISH
cytokine inducible SH2 containing protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr 3:50,531,870...50,537,319
Ensembl chr 3:51,769,194...51,774,548
G
CNTN3
contactin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17597826
NCBI chr 3:74,203,074...74,555,980
Ensembl chr 3:76,126,857...76,384,431
G
CREM
cAMP responsive element modulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr10:35,247,426...35,335,545
Ensembl chr10:35,825,218...35,912,432
G
CTSC
cathepsin C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr11:83,299,827...83,345,383
Ensembl chr11:86,890,010...86,933,847
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11312644 PMID:19022366
NCBI chr15:53,664,968...53,672,277
Ensembl chr15:73,284,566...73,290,636
G
EMB
embigin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr 5:63,590,589...63,635,167
Ensembl chr 5:65,204,168...65,247,182
G
ETS2
ETS proto-oncogene 2, transcription factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr21:25,158,457...25,178,035
Ensembl chr21:38,512,835...38,527,651
G
F13A1
coagulation factor XIII A chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr 6:5,978,505...6,156,705
Ensembl chr 6:6,157,926...6,513,961
G
FGL2
fibrinogen like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr 7:69,114,082...69,120,575
Ensembl chr 7:82,926,266...82,932,550
G
FLT1
fms related receptor tyrosine kinase 1
ISO
mRNA:protein:skin:
RGD
PMID:7876550
RGD:7421586
NCBI chr13:9,584,850...9,779,542
G
FYB1
FYN binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr 5:71,100,184...71,268,471
G
GRK2
G protein-coupled receptor kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr11:62,624,647...62,644,846
Ensembl chr11:65,939,164...65,959,066
G
HSD11B1
hydroxysteroid 11-beta dehydrogenase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr 1:185,262,599...185,311,417
Ensembl chr 1:190,086,449...190,116,765
G
IFI30
IFI30 lysosomal thiol reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17597826
NCBI chr19:17,652,935...17,657,239
Ensembl chr19:18,629,663...18,635,046
G
IFNG
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11312644 PMID:12484431 PMID:15347381
NCBI chr12:65,663,764...65,668,732
Ensembl chr12:68,448,861...68,453,829
G
IGSF6
immunoglobulin superfamily member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr16:15,668,232...15,680,218
Ensembl chr16:87,989,104...88,000,632
G
IL10
interleukin 10
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15347381 PMID:23760007
RGD:7364806
NCBI chr 1:182,369,234...182,374,207
Ensembl chr 1:186,648,289...186,653,371
G
IL18
interleukin 18
treatment
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:skin
RGD CTD
PMID:9781803 PMID:12874202 PMID:27585668
RGD:8655902 RGD:8655940
NCBI chr11:107,024,376...107,045,194
Ensembl chr11:110,867,586...110,888,371
G
IL18BP
interleukin 18 binding protein
treatment
ISO
RGD
PMID:12874202
RGD:8655940
NCBI chr11:67,078,251...67,083,043
Ensembl chr11:70,302,923...70,307,511
G
IL1A
interleukin 1 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23178550
NCBI chr2A:89,273,482...89,284,421
Ensembl chr2A:113,784,854...113,795,801
G
IL2
interleukin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11312644 PMID:22245253
NCBI chr 4:114,637,328...114,642,586
Ensembl chr 4:125,782,563...125,787,984
G
IL2RA
interleukin 2 receptor subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr10:6,053,549...6,103,863
G
IL32
interleukin 32
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17597826
NCBI chr16:2,007,018...2,023,757
Ensembl chr16:3,179,637...3,203,929
G
IL4
interleukin 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12484431 PMID:21804303
NCBI chr 5:128,091,342...128,099,886
Ensembl chr 5:134,253,039...134,261,581
G
IL5
interleukin 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15347381
NCBI chr 5:127,955,377...127,961,726
Ensembl chr 5:134,119,608...134,121,675
G
IPCEF1
interaction protein for cytohesin exchange factors 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr 6:151,975,688...152,173,692
G
ITGAM
integrin subunit alpha M
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr16:23,634,476...23,707,147
Ensembl chr16:31,630,146...31,702,406
G
JAM2
junctional adhesion molecule 2
ISO
RGD
PMID:16297198
RGD:7488919
NCBI chr21:12,084,083...12,162,615
Ensembl chr21:25,441,765...25,519,304
G
JAM3
junctional adhesion molecule 3
ISO
RGD
PMID:16297198
RGD:7488919
NCBI chr11:128,916,024...129,006,497
Ensembl chr11:132,783,580...132,864,657
G
KDR
kinase insert domain receptor
ISO
mRNA:protein:skin:
RGD
PMID:7876550
RGD:7421586
NCBI chr 4:68,813,894...68,861,018
Ensembl chr 4:75,377,375...75,427,109
G
KMO
kynurenine 3-monooxygenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr 1:217,094,037...217,157,827
Ensembl chr 1:222,075,268...222,138,866
G
LOC100974886
uncharacterized LOC100974886
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23178550
NCBI chr 4:50,092,989...50,095,541
Ensembl chr 4:55,925,562...55,986,555
G
LOC100979946
T-cell surface glycoprotein CD3 delta chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17597826
NCBI chr11:113,174,007...113,179,244
Ensembl chr11:117,105,868...117,111,051
G
MC1R
melanocortin 1 receptor
ISO
RGD
PMID:20126537
RGD:5687319
NCBI chr16:70,676,447...70,697,636
G
MEOX1
mesenchyme homeobox 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr17:13,733,235...13,756,584
Ensembl chr17:13,982,668...14,003,820
G
MKI67
marker of proliferation Ki-67
ISO
RGD
PMID:21294775
RGD:6483538
NCBI chr10:124,684,336...124,714,143
Ensembl chr10:128,936,037...128,962,555
G
MMP3
matrix metallopeptidase 3
ISO
mRNA:increased expression:skin, lymph node
RGD
PMID:10359808 PMID:16977379
RGD:2325935 RGD:8693317
NCBI chr11:97,776,729...97,784,549
Ensembl chr11:101,267,566...101,275,354
G
MMP9
matrix metallopeptidase 9
ISO
mRNA:increased expression:skin, lymph node
RGD
PMID:10359808 PMID:10415717 PMID:16977379
RGD:2325935 RGD:8547869 RGD:8693317
NCBI chr20:42,346,305...42,354,018
Ensembl chr20:43,432,389...43,440,129
G
MRC1
mannose receptor C-type 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr10:18,128,280...18,230,438
Ensembl chr10:18,398,310...18,500,367
G
MXD1
MAX dimerization protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr2A:69,957,798...70,002,615
Ensembl chr2A:71,074,998...71,102,838
G
NAMPT
nicotinamide phosphoribosyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr 7:98,227,071...98,262,254
Ensembl chr 7:110,952,876...110,981,967
G
NAT1
N-acetyltransferase 1
susceptibility
ISO
DNA:polymorphism: :
RGD
PMID:19663877
RGD:8552666
NCBI chr 8:17,425,852...17,439,684
Ensembl chr 8:14,386,481...14,392,462
G
NAT2
N-acetyltransferase 2
susceptibility
ISO
DNA:polymorphisms: :
RGD
PMID:16533241
RGD:8552663
NCBI chr 8:17,606,445...17,623,397
Ensembl chr 8:14,575,455...14,576,327
G
NFE2L2
NFE2 like bZIP transcription factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23564646
NCBI chr2B:64,509,446...64,544,600
Ensembl chr2B:182,214,116...182,248,085
G
NINJ1
ninjurin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr 9:64,245,086...64,258,614
Ensembl chr 9:92,311,502...92,324,030
G
NUMA1
nuclear mitotic apparatus protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr11:67,083,378...67,160,747
Ensembl chr11:70,307,847...70,384,425
G
OGG1
8-oxoguanine DNA glycosylase
ISO
RGD
PMID:15677345
RGD:8657146
NCBI chr 3:9,702,311...9,742,283
Ensembl chr 3:9,940,955...9,947,335
G
PHLDA1
pleckstrin homology like domain family A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr12:73,530,456...73,543,951
Ensembl chr12:76,387,313...76,388,502
G
PIM1
Pim-1 proto-oncogene, serine/threonine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr 6:36,730,669...36,735,954
G
PLAT
plasminogen activator, tissue type
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr 8:41,419,415...41,451,951
Ensembl chr 8:38,864,918...38,897,779
G
PRDX4
peroxiredoxin 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr X:16,266,501...16,285,458
Ensembl chr X:23,641,701...23,660,267
G
QPCT
glutaminyl-peptide cyclotransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr2A:37,371,848...37,400,820
Ensembl chr2A:38,136,532...38,165,254
G
RAB32
RAB32, member RAS oncogene family
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr 6:144,339,323...144,354,885
G
RGS1
regulator of G protein signaling 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr 1:168,039,235...168,043,516
Ensembl chr 1:172,333,866...172,337,401
G
SAT1
spermidine/spermine N1-acetyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr X:16,382,735...16,385,790
Ensembl chr X:23,756,691...23,760,349
G
SELE
selectin E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17597826
NCBI chr 1:145,205,684...145,217,143
Ensembl chr 1:148,930,437...148,938,313
G
SLC2A3
solute carrier family 2 member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr12:8,045,058...8,062,116
Ensembl chr12:8,408,457...8,423,466
G
SLC7A5
solute carrier family 7 member 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr16:68,512,407...68,552,763
G
SOCS1
suppressor of cytokine signaling 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr16:10,196,432...10,198,205
G
SOCS2
suppressor of cytokine signaling 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr12:91,115,319...91,134,191
Ensembl chr12:94,514,455...94,520,748
G
SPP1
secreted phosphoprotein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14555839
NCBI chr 4:80,263,711...80,271,466
Ensembl chr 4:90,988,200...90,995,935
G
ST6GAL1
ST6 beta-galactoside alpha-2,6-sialyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr 3:183,955,462...184,104,537
Ensembl chr 3:192,488,087...192,569,970
G
STAC
SH3 and cysteine rich domain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr 3:36,287,485...36,457,151
Ensembl chr 3:36,578,543...36,747,971
G
TAP2
transporter 2, ATP binding cassette subfamily B member
susceptibility
ISO
RGD
PMID:9303338
RGD:6482276
NCBI chr 6:32,394,586...32,408,297
Ensembl chr 6:33,507,332...33,523,750
G
TLR4
toll like receptor 4
ISO
RGD
PMID:18725520 PMID:20711192
RGD:7777133 RGD:7794737
NCBI chr 9:88,827,495...88,840,458
Ensembl chr 9:117,180,550...117,190,711
G
TLR7
toll like receptor 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr X:5,479,247...5,504,810
Ensembl chr X:12,767,981...12,790,517
G
TMSB10
thymosin beta 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17597826
NCBI chr2A:84,958,267...84,959,382
Ensembl chr2A:86,517,393...86,517,799
G
TNF
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15849067
NCBI chr 6:31,236,650...31,239,423
Ensembl chr 6:32,126,618...32,129,381
G
TNFAIP6
TNF alpha induced protein 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404 PMID:17374397
NCBI chr2B:38,669,652...38,692,037
Ensembl chr2B:155,933,842...155,956,382
G
TSLP
thymic stromal lymphopoietin
treatment
ISO
RGD
PMID:30187507
RGD:38596345
NCBI chr 5:106,440,136...106,446,849
Ensembl chr 5:112,242,490...112,250,130
G
UPP1
uridine phosphorylase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr 7:48,729,975...48,749,598
Ensembl chr 7:48,838,893...48,858,185
G
VEGFA
vascular endothelial growth factor A
ISO
mRNA:protein:skin:
RGD
PMID:7876550
RGD:7421586
NCBI chr 6:43,361,053...43,377,366
Ensembl chr 6:44,650,365...44,666,353
G
ACTL9
actin like 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23042114
NCBI chr19:7,992,891...7,994,357
Ensembl chr19:8,837,899...8,839,149
G
ADAM17
ADAM metallopeptidase domain 17
ISO
OMIM:603165
MouseDO
NCBI chr2A:9,478,080...9,545,363
Ensembl chr2A:9,641,201...9,708,054
G
AHR
aryl hydrocarbon receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27869817
NCBI chr 7:17,949,254...17,998,737
Ensembl chr 7:17,278,637...17,326,171
G
APOE
apolipoprotein E
ISO
protein:decreased expression:plasma
RGD
PMID:19116453
RGD:11040546
NCBI chr19:41,853,669...41,857,252
Ensembl chr19:50,459,906...50,463,490
G
ARTN
artemin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27869817
NCBI chr 1:43,233,097...43,239,044
G
BDNF
brain derived neurotrophic factor
susceptibility no_association
ISO
protein:increased expression:serum: mRNA:decreased expression:mast cell DNA:polymorphism::C270T(human) DNA:polymorphism:cds:p.V66M(human)
RGD
PMID:17073871 PMID:17845420 PMID:19038326 PMID:19522715
RGD:8657028 RGD:8657065 RGD:8657067 RGD:8657069
NCBI chr11:27,618,322...27,687,661
Ensembl chr11:27,520,312...27,589,239
G
C3
complement C3
ISO
protein:increased expression:plasma
RGD
PMID:3923750
RGD:7401273
NCBI chr19:5,708,211...5,753,178
Ensembl chr19:6,629,287...6,674,699
G
CARD11
caspase recruitment domain family member 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23042114 PMID:28628108
NCBI chr 7:3,166,788...3,304,729
Ensembl chr 7:3,258,736...3,332,999
G
CASP8
caspase 8
ISO
OMIM:603165
MouseDO
NCBI chr2B:88,490,611...88,542,132
Ensembl chr2B:206,669,544...206,696,468
G
CCDC80
coiled-coil domain containing 80
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23042114
NCBI chr 3:109,753,743...109,789,769
Ensembl chr 3:116,678,161...116,712,611
G
CCL17
C-C motif chemokine ligand 17
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18249437
NCBI chr16:37,678,518...37,689,350
Ensembl chr16:56,819,949...56,822,131
G
CCL20
C-C motif chemokine ligand 20
treatment severity
ISO
protein:increased expression:plasma
RGD
PMID:11133838 PMID:19162238
RGD:7483580 RGD:7483583
NCBI chr2B:115,052,768...115,056,479
Ensembl chr2B:233,862,505...233,866,225
G
CCL22
C-C motif chemokine ligand 22
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18249437 PMID:22125604
NCBI chr16:37,631,861...37,640,208
Ensembl chr16:56,765,367...56,771,213
G
CCL24
C-C motif chemokine ligand 24
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18249437
NCBI chr 7:68,206,688...68,210,343
Ensembl chr 7:82,263,310...82,265,480
G
CCL26
C-C motif chemokine ligand 26
ISO
protein:increased expression:serum (human)
RGD
PMID:14616792
RGD:11087554
NCBI chr 7:68,230,804...68,251,369
Ensembl chr 7:82,221,846...82,242,874
G
CCL27
C-C motif chemokine ligand 27
ISO
RGD
PMID:12642842
RGD:1626250
NCBI chr 9:34,498,478...34,501,475
Ensembl chr 9:35,307,175...35,308,146
G
CCL28
C-C motif chemokine ligand 28
severity
ISO
associated with Asthma; protein: increased secretion:serum (human)
RGD
PMID:20161852
RGD:4892193
NCBI chr 5:66,977,643...66,998,420
Ensembl chr 5:72,012,579...72,046,031
G
CCL5
C-C motif chemokine ligand 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18249437
NCBI chr17:20,915,198...20,923,530
Ensembl chr17:21,210,798...21,219,172
G
CCR2
C-C motif chemokine receptor 2
ISO
protein:increased expression:skin,monocyte:
RGD
PMID:15370700
RGD:8661734
NCBI chr 3:46,255,725...46,263,285
Ensembl chr 3:47,361,124...47,368,312
G
CCR3
C-C motif chemokine receptor 3
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:skin
CTD RGD
PMID:16449815 PMID:18249437
RGD:6893391
NCBI chr 3:46,147,928...46,172,947
Ensembl chr 3:47,253,878...47,278,630
G
CCR5
C-C motif chemokine receptor 5
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16449815 PMID:18249437
RGD:6893391
NCBI chr 3:46,273,096...46,278,471
Ensembl chr 3:47,380,321...47,381,379
G
CD40
CD40 molecule
ISO
RGD
PMID:18693155
RGD:5132274
NCBI chr20:42,455,711...42,467,139
Ensembl chr20:43,541,619...43,552,994
G
CDSN
corneodesmosin
ISO
protein:decreased expression:skin of body (human)
RGD
PMID:21211653
RGD:42721970
NCBI chr 6:30,861,199...30,867,082
Ensembl chr 6:31,727,090...31,731,976
G
CLDN1
claudin 1
ISO
mRNA,protein:decreased expression:epidermis:
RGD
PMID:21163515
RGD:11344875
NCBI chr 3:187,328,629...187,345,360
Ensembl chr 3:195,882,239...195,899,248
G
CLDN23
claudin 23
ISO
mRNA:decreased expression:epidermis:
RGD
PMID:21163515
RGD:11344875
NCBI chr 8:10,510,323...10,512,467
G
CMA1
chymase 1
ISO
DNA:polymorphism:5' utr:g.-1903G>A rs1800875 (human)
RGD
PMID:16134991
RGD:1625394
NCBI chr14:5,277,269...5,280,335
Ensembl chr14:23,400,345...23,403,548
G
CTLA4
cytotoxic T-lymphocyte associated protein 4
susceptibility
ISO
mRNA:increased expression:blood: DNA:SNP,haplotype:exon,3'UTR:rs3087243,rs231775 (human)
RGD
PMID:16445777 PMID:22357516
RGD:7411698 RGD:7411700
NCBI chr2B:91,054,917...91,106,234
Ensembl chr2B:209,239,417...209,244,498
G
CTSE
cathepsin E
ISO
OMIM:603165
MouseDO
NCBI chr 1:181,617,421...181,632,260
Ensembl chr 1:185,900,746...185,915,519
G
CX3CL1
C-X3-C motif chemokine ligand 1
ISO
protein:increased expression:serum
RGD
PMID:15131578
RGD:9491761
NCBI chr16:37,646,447...37,659,078
Ensembl chr16:56,779,065...56,791,760
G
CX3CR1
C-X3-C motif chemokine receptor 1
ISO
protein:decreased expression:blood, leukocyte
RGD
PMID:15131578 PMID:24821910
RGD:9491393 RGD:9491761
NCBI chr 3:39,158,346...39,176,604
Ensembl chr 3:39,440,955...39,457,219
G
CXCL10
C-X-C motif chemokine ligand 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18249437
NCBI chr 4:48,182,355...48,184,733
Ensembl chr 4:54,020,204...54,022,606
G
CXCR3
C-X-C motif chemokine receptor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18249437
NCBI chr X:60,880,759...60,883,355
Ensembl chr X:70,933,160...70,935,756
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27869817
NCBI chr15:53,664,968...53,672,277
Ensembl chr15:73,284,566...73,290,636
G
CYP4F22
cytochrome P450 family 4 subfamily F member 22
ISO
ClinVar Annotator: match by term: Atopic eczema
ClinVar
PMID:25741868
NCBI chr19:15,039,212...15,083,771
Ensembl chr19:16,041,583...16,068,490
G
DOCK8
dedicator of cytokinesis 8
ISO
DNA:mutations:cds:
RGD
PMID:22476911
RGD:40903056
NCBI chr 9:6,791...256,837
Ensembl chr 9:201,156...446,910
G
EMSY
EMSY transcriptional repressor, BRCA2 interacting
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23042114
NCBI chr11:71,496,577...71,604,230
G
F2
coagulation factor II, thrombin
ISO
protein:increased expression:plasma
RGD
PMID:21488867
RGD:5147756
NCBI chr11:46,669,925...46,690,391
Ensembl chr11:47,227,891...47,249,157
G
FLG
filaggrin
ISO
ClinVar Annotator: match by term: Atopic eczema
ClinVar
PMID:3163778 PMID:16444271 PMID:16550169 PMID:16815158 PMID:17030239 PMID:18325573 PMID:19501237 PMID:19839980 PMID:19874431 PMID:21514438 PMID:22403702 PMID:23947670 PMID:24033266 PMID:24920311 PMID:25741868 PMID:27279822 PMID:27363669 PMID:31637781 More...
NCBI chr 1:127,634,416...127,649,659
G
GLB1
galactosidase beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23042114
NCBI chr 3:32,892,039...33,031,959
Ensembl chr 3:33,231,209...33,336,804
G
GSTM1
glutathione S-transferase mu 1
susceptibility
ISO
DNA:deletion: :
RGD
PMID:20674822 PMID:21176116
RGD:5490539 RGD:5490981
Ensembl chr 1:127,979,238...128,010,411
G
GSTP1
glutathione S-transferase pi 1
susceptibility
ISO
DNA:polymorphism:exon:p.I105V (rs1695) (human)
RGD
PMID:19842992 PMID:20674822
RGD:5490540 RGD:5490981
NCBI chr11:62,942,756...62,945,701
Ensembl chr11:66,253,421...66,256,472
G
HAVCR1
hepatitis A virus cellular receptor 1
ISO
RGD
PMID:16159638
RGD:5128852
NCBI chr 5:152,429,337...152,459,800
Ensembl chr 5:158,413,073...158,442,481
G
HNMT
histamine N-methyltransferase
ISO
RGD
PMID:19025430
RGD:5128889
NCBI chr2B:21,840,342...21,892,744
Ensembl chr2B:142,036,321...142,088,315
G
IFNG
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:18249437 PMID:22101570 PMID:33274957
RGD:8157618
NCBI chr12:65,663,764...65,668,732
Ensembl chr12:68,448,861...68,453,829
G
IFNL3
interferon lambda 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22295096
NCBI chr19:36,341,396...36,343,261
G
IL10
interleukin 10
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18249437 PMID:23843958
RGD:7364805
NCBI chr 1:182,369,234...182,374,207
Ensembl chr 1:186,648,289...186,653,371
G
IL13
interleukin 13
severity treatment
ISO
DNA, protein:SNP, increased expression:promoter, serum:-1112C>T (human) OMIM:603165 DNA:SNP:exon:4257G>A (human) CTD Direct Evidence: marker/mechanism DNA:SNPs: :rs3091307, rs20541 (human)
RGD MouseDO CTD
PMID:10887320 PMID:16672002 PMID:17313488 PMID:18249437 PMID:19006098 PMID:21913997 PMID:22355542 PMID:23317483 More...
RGD:5684364 RGD:8549509 RGD:8549529 RGD:8549531 RGD:8549539 RGD:8549583
NCBI chr 5:128,073,863...128,078,453
Ensembl chr 5:134,235,788...134,240,548
G
IL13RA1
interleukin 13 receptor subunit alpha 1
ISO
mRNA:increased expression:skin
RGD
PMID:14527737
RGD:8549525
NCBI chr X:107,735,233...107,813,282
Ensembl chr X:118,202,285...118,266,770
G
IL13RA2
interleukin 13 receptor subunit alpha 2
ISO
protein:increased expression:serum
RGD
PMID:20971924 PMID:21462799
RGD:8549521 RGD:8549556
NCBI chr X:104,092,993...104,146,062
Ensembl chr X:114,597,077...114,635,253
G
IL17A
interleukin 17A
severity treatment
ISO
protein:increased expression:dermis, lymphocyte (human) protein:increased expression:epidermis (mouse)
RGD
PMID:18432274 PMID:22848348 PMID:24337738
RGD:8698670 RGD:9068417 RGD:9068436
NCBI chr 6:51,736,269...51,740,538
Ensembl chr 6:53,004,820...53,009,074
G
IL18
interleukin 18
severity no_association
ISO
DNA:SNP:promoter:-140C>G (rs360721) (human) OMIM:603165 protein:increased expression:serum DNA:SNP:promoter:-137G>C (rs187238) (human) DNA:SNPs, haplotype: :rs795467, rs4937113, rs5744247 (human)
RGD MouseDO
PMID:11490156 PMID:15317323 PMID:17517100 PMID:22840759
RGD:8655872 RGD:8655876 RGD:8655908 RGD:8655914
NCBI chr11:107,024,376...107,045,194
Ensembl chr11:110,867,586...110,888,371
G
IL1B
interleukin 1 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18249437
NCBI chr2A:89,216,313...89,223,358
Ensembl chr2A:113,846,306...113,853,424
G
IL2
interleukin 2
susceptibility
ISO
associated with food hypersensitivity; protein:increased expression:CD8+ T cell: DNA:SNP:promoter:rs2069762(human)
RGD
PMID:1673687 PMID:7547077 PMID:16333313 PMID:16672002 PMID:21982597
RGD:8549583 RGD:8662961 RGD:8663444 RGD:8663473 RGD:8693325
NCBI chr 4:114,637,328...114,642,586
Ensembl chr 4:125,782,563...125,787,984
G
IL21R
interleukin 21 receptor
ISO
protein:increased expression:skin
RGD
PMID:19075398
RGD:6892938
Ensembl chr16:27,774,864...27,821,769
G
IL23A
interleukin 23 subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33274957
NCBI chr12:32,575,321...32,576,856
Ensembl chr12:32,828,902...32,830,617
G
IL25
interleukin 25
ISO
protein:increased expression:arm skin
RGD
PMID:23657503
RGD:39128244
NCBI chr14:4,191,888...4,195,043
Ensembl chr14:22,286,347...22,289,498
G
IL31
interleukin 31
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18249437
NCBI chr12:119,773,030...119,775,963
Ensembl chr12:123,140,531...123,142,700
G
IL32
interleukin 32
ISO
mRNA:splice variant:zone of skin (human)
RGD
PMID:28301691
RGD:150340720
NCBI chr16:2,007,018...2,023,757
Ensembl chr16:3,179,637...3,203,929
G
IL33
interleukin 33
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18249437
NCBI chr 9:6,027,014...6,069,540
Ensembl chr 9:6,234,178...6,248,624
G
IL4
interleukin 4
ISO
DNA:SNP:promoter:-590C>T (human) OMIM:603165 CTD Direct Evidence: marker/mechanism protein:increased expression:serum
RGD MouseDO CTD
PMID:8363440 PMID:9643293 PMID:11886533 PMID:12230500 PMID:18249437
RGD:7829786 RGD:7829795
NCBI chr 5:128,091,342...128,099,886
Ensembl chr 5:134,253,039...134,261,581
G
IL4R
interleukin 4 receptor
susceptibility
ISO
DNA:mutation:cds:p.Q576R(human)
RGD
PMID:9392697
RGD:11530001
Ensembl chr16:27,642,702...27,737,445
G
IL5
interleukin 5
ISO
mRNA: increased expression: skin CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:11886533 PMID:18249437 PMID:22299064 PMID:33274957
RGD:5687175
NCBI chr 5:127,955,377...127,961,726
Ensembl chr 5:134,119,608...134,121,675
G
IL6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18249437
NCBI chr 7:23,415,922...23,420,767
G
KCNJ11
potassium inwardly rectifying channel subfamily J member 11
ISO
ClinVar Annotator: match by term: Atopic eczema
ClinVar
NCBI chr11:17,440,522...17,444,075
Ensembl chr11:17,127,557...17,128,729
G
LOC100980531
eotaxin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18249437
NCBI chr17:22,495,737...22,515,144
Ensembl chr17:22,806,076...22,808,345 Ensembl chr17:22,806,076...22,808,345
G
LOC100991644
low affinity immunoglobulin gamma Fc region receptor II-a
severity
ISO
protein:increased expression:eosinophil
RGD
PMID:7564170
RGD:5147985
NCBI chr 1:136,892,311...136,906,450
G
MAPK8
mitogen-activated protein kinase 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24046278
NCBI chr10:45,806,748...45,936,362
G
MBL2
mannose binding lectin 2
susceptibility
ISO
DNA:polymorphisms:promoter, exon:
RGD
PMID:20642202
RGD:8693720
NCBI chr10:49,401,364...49,409,328
Ensembl chr10:51,527,758...51,543,432
G
MC1R
melanocortin 1 receptor
ISO
protein: increased expression: skin
RGD
PMID:19889022
RGD:5687321
NCBI chr16:70,676,447...70,697,636
G
MMP9
matrix metallopeptidase 9
treatment
ISO
RGD
PMID:27776525
RGD:13204759
NCBI chr20:42,346,305...42,354,018
Ensembl chr20:43,432,389...43,440,129
G
MS4A2
membrane spanning 4-domains A2
susceptibility
ISO
Atopy and bronchial hyperresponsiveness, OMIM:147050 DNA:polymorphism:CDS:amino acid E237G
RGD
PMID:8817330
RGD:1599903
NCBI chr11:55,318,843...55,326,779
Ensembl chr11:58,764,911...58,772,567
G
NAT2
N-acetyltransferase 2
no_association susceptibility
ISO
DNA:polymorphisms: :481C>T,590G>A,857G>A(human) DNA:polymorphisms: :481C>T, 590G>A(human)
RGD
PMID:14528063 PMID:16224574
RGD:8552664 RGD:8552668
NCBI chr 8:17,606,445...17,623,397
Ensembl chr 8:14,575,455...14,576,327
G
NFKBIA
NFKB inhibitor alpha
ISO
OMIM:603165
MouseDO
NCBI chr14:16,155,331...16,158,588
G
NFKBIZ
NFKB inhibitor zeta
ISO
OMIM:603165
MouseDO
NCBI chr 3:98,914,957...98,948,467
Ensembl chr 3:105,616,645...105,628,300
G
NGF
nerve growth factor
ISO
protein:increased expression:serum:
RGD
PMID:17073871
RGD:8657069
NCBI chr 1:87,223,597...87,276,759
G
NGFR
nerve growth factor receptor
ISO
protein:increased expression:nerve fibers of the papillary dermis
RGD
PMID:16586073
RGD:5508452
NCBI chr17:8,089,600...8,109,361
Ensembl chr17:8,075,316...8,094,966
G
NTRK1
neurotrophic receptor tyrosine kinase 1
ISO
protein:increased expression:eosinophil
RGD
PMID:17223862 PMID:18647313
RGD:5144116 RGD:5684771
Ensembl chr 1:136,007,476...136,047,355
G
OVOL1
ovo like transcriptional repressor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23042114
NCBI chr11:61,144,969...61,156,706
Ensembl chr11:64,478,549...64,488,647
G
PPARA
peroxisome proliferator activated receptor alpha
ISO
CTD Direct Evidence: marker/mechanism potential therapeutic target with or without glucocorticoid therapy
CTD RGD
PMID:18249437 PMID:21633371
RGD:5509940
Ensembl chr22:45,218,364...45,302,970
G
PPIA
peptidylprolyl isomerase A
ISO
mRNA:increased expression:zone of skin (human)
RGD
PMID:32496587
RGD:150383342
NCBI chr 7:45,510,450...45,515,448
Ensembl chr 7:45,578,765...45,605,545
G
RELB
RELB proto-oncogene, NF-kB subunit
ISO
OMIM:603165
RGD MouseDO
PMID:10940923
RGD:7777149
NCBI chr19:41,948,559...41,987,121
Ensembl chr19:50,554,864...50,590,223
G
S100A8
S100 calcium binding protein A8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18336422
NCBI chr 1:128,741,378...128,742,520
Ensembl chr 1:132,370,435...132,371,591
G
SELE
selectin E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12410700
NCBI chr 1:145,205,684...145,217,143
Ensembl chr 1:148,930,437...148,938,313
G
SELP
selectin P
ISO
atopy and bronchial hyperresponsiveness, OMIM:147050 DNA:point_mutation:CDS:amino acid Val640Leu
RGD
PMID:12929084
RGD:1599904
NCBI chr 1:145,071,094...145,112,851
Ensembl chr 1:148,793,677...148,834,701
G
SHARPIN
SHANK associated RH domain interactor
ISO
OMIM:603165
MouseDO
NCBI chr 8:140,865,009...140,870,580
Ensembl chr 8:143,854,902...143,862,888
G
SHOC2
SHOC2 leucine rich repeat scaffold protein
ISO
associated with Noonan syndrome and related diseases; DNA:mutation:cds:c.4A>G (p.S2G)(human)
RGD
PMID:20882035
RGD:11071178
NCBI chr10:107,512,795...107,606,627
Ensembl chr10:110,993,556...111,055,312
G
SLC11A1
solute carrier family 11 member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16597321
NCBI chr2B:105,640,613...105,655,524
Ensembl chr2B:224,238,284...224,252,941
G
STAT6
signal transducer and activator of transcription 6
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15306842
Ensembl chr12:32,068,679...32,085,099
G
TGFB1
transforming growth factor beta 1
ISO
RGD
PMID:11496247
RGD:7394812
NCBI chr19:38,324,009...38,347,003
Ensembl chr19:46,831,659...46,852,973
G
TLR2
toll like receptor 2
severity
ISO
DNA:polymorphism: :-16934A>T(human) DNA:polymorphism:cds:p.R753Q(human)
RGD
PMID:17531301 PMID:19627277 PMID:22032785
RGD:8552997 RGD:8552999 RGD:8553048
NCBI chr 4:146,024,653...146,091,388
Ensembl chr 4:157,866,977...157,869,331
G
TLR4
toll like receptor 4
ISO
DNA:polymorphism: :896G>A(human) mRNA:increased expression:blood cell:
RGD
PMID:19764566 PMID:23821954
RGD:7794689 RGD:7794745
NCBI chr 9:88,827,495...88,840,458
Ensembl chr 9:117,180,550...117,190,711
G
TMEM79
transmembrane protein 79
ISO
OMIM:603165
MouseDO
NCBI chr 1:131,625,864...131,635,370
Ensembl chr 1:135,455,766...135,465,426
G
TNF
tumor necrosis factor
susceptibility
ISO
DNA:haplotype:promoter:−308G>A,-238G>A(human)
RGD
PMID:22533231
RGD:7401246
NCBI chr 6:31,236,650...31,239,423
Ensembl chr 6:32,126,618...32,129,381
G
TNFAIP6
TNF alpha induced protein 6
ISO
mRNA:altered expression:fibroblast
RGD
PMID:16650051
RGD:7777183
NCBI chr2B:38,669,652...38,692,037
Ensembl chr2B:155,933,842...155,956,382
G
TRAF3IP2
TRAF3 interacting protein 2
ISO
OMIM:603165
MouseDO
NCBI chr 6:109,367,333...109,414,601
Ensembl chr 6:113,444,005...113,485,533
G
TRPV3
transient receptor potential cation channel subfamily V member 3
ISO
OMIM:603165
MouseDO
NCBI chr17:3,528,734...3,577,162
Ensembl chr17:3,516,209...3,603,787
G
TSLP
thymic stromal lymphopoietin
treatment
ISO
CTD Direct Evidence: marker/mechanism OMIM:603165
CTD MouseDO RGD
PMID:16880407 PMID:22355542 PMID:23688403 PMID:27869817 PMID:29310423
RGD:38549374
NCBI chr 5:106,440,136...106,446,849
Ensembl chr 5:112,242,490...112,250,130
G
VDR
vitamin D receptor
no_association severity
ISO
DNA:SNP: :rs2228570 (human) DNA:SNPs, haplotype: :rs731236, rs1544410, rs7975232 (human)
RGD
PMID:23034014
RGD:8157625
NCBI chr12:40,828,413...40,891,700
Ensembl chr12:41,702,742...41,766,192
G
VNN1
vanin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19322213
NCBI chr 6:130,459,268...130,491,167
Ensembl chr 6:134,566,117...134,598,784
G
VNN2
vanin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19322213
NCBI chr 6:130,521,698...130,535,944
Ensembl chr 6:134,629,464...134,643,934
G
WASL
WASP like actin nucleation promoting factor
ISO
OMIM:603165
MouseDO
NCBI chr 7:115,675,170...115,741,498
Ensembl chr 7:128,360,495...128,385,393
G
FLG
filaggrin
ISO
ClinVar Annotator: match by term: Dermatitis, atopic, 2 | ClinVar Annotator: match by term: Dermatitis, atopic, 2, susceptibility to
OMIM ClinVar
PMID:3163778 PMID:16444271 PMID:16550169 PMID:16815158 PMID:17030239 PMID:17291859 PMID:17417636 PMID:18325573 PMID:18396323 PMID:19183181 PMID:19501237 PMID:19785597 PMID:19839980 PMID:19874431 PMID:20674819 PMID:21039602 PMID:21377035 PMID:21514438 PMID:22403702 PMID:22407025 PMID:22951058 PMID:22995991 PMID:23039796 PMID:23301728 PMID:23947670 PMID:24033266 PMID:24077912 PMID:24565632 PMID:24608987 PMID:24920311 PMID:25314673 PMID:25741868 PMID:26451970 PMID:27279822 PMID:27363669 PMID:28143684 PMID:29428354 PMID:29444371 PMID:29791750 PMID:30665703 PMID:31365035 PMID:31637781 PMID:32066784 More...
NCBI chr 1:127,634,416...127,649,659
G
SLX1A
SLX1 homolog A, structure-specific endonuclease subunit
ISO
OMIM:227850
MouseDO
G
SLX4
SLX4 structure-specific endonuclease subunit
ISO
OMIM:227850
MouseDO
NCBI chr16:2,502,334...2,532,172
Ensembl chr16:3,678,018...3,707,842
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all